Pfizer and BioNTech's Vaccine Approved in the UK
Pfizer and BioNTech's vaccine was approved in the UK. The UK has been registered as the first western country to approve the coronavirus vaccine developed jointly by regulatory agencies Pfizer and BioNTech.
The coronavirus vaccine, which was developed by Pfizer and BioNTech and has 95 percent efficiency, was approved by regulatory agencies in the UK.
With the emergency approval, the obstacles to the supply of the vaccine were removed and a new page was opened in the fight against coronavirus.
In a statement in November, Pfizer and its German partner
BioNTech stated that the vaccine developed was based on a new technology called "carrier RNA" and stated that the vaccine had 95 percent efficiency in the final test results.
According to the statement made by the UK government, the vaccine will be available in the UK next week.